Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117850025 | 11785002 | 5 | F | 2013 | 20160920 | 20151130 | 20160922 | EXP | CA-ROCHE-1141931 | ROCHE | 54.08 | YR | F | Y | 118.00000 | KG | 20160922 | OT | CA | CA |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 117850025 | 11785002 | 1 | PS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B20172,B20262,B2042,B2043 | 125276 | 800 | MG | SOLUTION FOR INFUSION | /month | |||||
| 117850025 | 11785002 | 2 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B20172,B20262,B2042,B2043 | 125276 | SOLUTION FOR INFUSION | ||||||||
| 117850025 | 11785002 | 3 | SS | ACTEMRA | TOCILIZUMAB | 1 | Intravenous (not otherwise specified) | Y | B20172,B20262,B2042,B2043 | 125276 | 800 | MG | SOLUTION FOR INFUSION | ||||||
| 117850025 | 11785002 | 4 | C | METHOTREXATE. | METHOTREXATE | 1 | 0 | ||||||||||||
| 117850025 | 11785002 | 5 | C | CRESTOR | ROSUVASTATIN CALCIUM | 1 | 0 | ||||||||||||
| 117850025 | 11785002 | 6 | C | FOLIC ACID. | FOLIC ACID | 1 | 0 | ||||||||||||
| 117850025 | 11785002 | 7 | C | ENDOCET | ACETAMINOPHENOXYCODONE HYDROCHLORIDE | 1 | 0 | ||||||||||||
| 117850025 | 11785002 | 8 | C | TECTA | PANTOPRAZOLE MAGNESIUM | 1 | 0 | ||||||||||||
| 117850025 | 11785002 | 9 | C | OLMETEC | OLMESARTAN MEDOXOMIL | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 117850025 | 11785002 | 1 | Rheumatoid arthritis |
| 117850025 | 11785002 | 9 | Blood pressure measurement |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 117850025 | 11785002 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 117850025 | 11785002 | Blood pressure abnormal | |
| 117850025 | 11785002 | Blood pressure fluctuation | |
| 117850025 | 11785002 | Blood pressure increased | |
| 117850025 | 11785002 | Blood pressure systolic decreased | |
| 117850025 | 11785002 | Blood urine present | |
| 117850025 | 11785002 | Bronchitis | |
| 117850025 | 11785002 | Cough | |
| 117850025 | 11785002 | Cystitis | |
| 117850025 | 11785002 | Dizziness | |
| 117850025 | 11785002 | Ear pain | |
| 117850025 | 11785002 | Headache | |
| 117850025 | 11785002 | Hepatic cirrhosis | |
| 117850025 | 11785002 | Hepatic steatosis | |
| 117850025 | 11785002 | Hypotension | |
| 117850025 | 11785002 | Infection | |
| 117850025 | 11785002 | Infusion related reaction | |
| 117850025 | 11785002 | Injection site extravasation | |
| 117850025 | 11785002 | Localised infection | |
| 117850025 | 11785002 | Malaise | |
| 117850025 | 11785002 | Menopausal symptoms | |
| 117850025 | 11785002 | Nasopharyngitis | |
| 117850025 | 11785002 | Nausea | |
| 117850025 | 11785002 | Nodule | |
| 117850025 | 11785002 | Oropharyngeal pain | |
| 117850025 | 11785002 | Pyrexia | |
| 117850025 | 11785002 | Skin infection | |
| 117850025 | 11785002 | Urine abnormality | |
| 117850025 | 11785002 | Uterine cancer | |
| 117850025 | 11785002 | Weight increased |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 117850025 | 11785002 | 1 | 20120905 | 0 | ||
| 117850025 | 11785002 | 2 | 20140602 | 20140602 | 0 |